144 related articles for article (PubMed ID: 36178218)
1. [Multifactorial assessment of prognostic features of adrenocortical cancer].
Porubayeva EE; Pachuashvili NV; Urusova LS
Arkh Patol; 2022; 84(5):20-27. PubMed ID: 36178218
[TBL] [Abstract][Full Text] [Related]
2. Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection.
Beuschlein F; Weigel J; Saeger W; Kroiss M; Wild V; Daffara F; Libé R; Ardito A; Al Ghuzlan A; Quinkler M; Oßwald A; Ronchi CL; de Krijger R; Feelders RA; Waldmann J; Willenberg HS; Deutschbein T; Stell A; Reincke M; Papotti M; Baudin E; Tissier F; Haak HR; Loli P; Terzolo M; Allolio B; Müller HH; Fassnacht M
J Clin Endocrinol Metab; 2015 Mar; 100(3):841-9. PubMed ID: 25559399
[TBL] [Abstract][Full Text] [Related]
3. S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study.
Elhassan YS; Altieri B; Berhane S; Cosentini D; Calabrese A; Haissaguerre M; Kastelan D; Fragoso MCBV; Bertherat J; Al Ghuzlan A; Haak H; Boudina M; Canu L; Loli P; Sherlock M; Kimpel O; Laganà M; Sitch AJ; Kroiss M; Arlt W; Terzolo M; Berruti A; Deeks JJ; Libé R; Fassnacht M; Ronchi CL
Eur J Endocrinol; 2021 Nov; 186(1):25-36. PubMed ID: 34709200
[TBL] [Abstract][Full Text] [Related]
4. Validation of the prognostic role of the "Helsinki Score" in 225 cases of adrenocortical carcinoma.
Duregon E; Cappellesso R; Maffeis V; Zaggia B; Ventura L; Berruti A; Terzolo M; Fassina A; Volante M; Papotti M
Hum Pathol; 2017 Apr; 62():1-7. PubMed ID: 27916625
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Role of Ki-67 in Adrenocortical Carcinoma After Primary Resection: A Retrospective Mono-Institutional Study.
Zhang F; Zhang F; Liu Z; Wu K; Zhu Y; Lu Y
Adv Ther; 2019 Oct; 36(10):2756-2768. PubMed ID: 31471770
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study.
Libé R; Borget I; Ronchi CL; Zaggia B; Kroiss M; Kerkhofs T; Bertherat J; Volante M; Quinkler M; Chabre O; Bala M; Tabarin A; Beuschlein F; Vezzosi D; Deutschbein T; Borson-Chazot F; Hermsen I; Stell A; Fottner C; Leboulleux S; Hahner S; Mannelli M; Berruti A; Haak H; Terzolo M; Fassnacht M; Baudin E;
Ann Oncol; 2015 Oct; 26(10):2119-25. PubMed ID: 26392430
[TBL] [Abstract][Full Text] [Related]
7. Myxoid and Sarcomatoid Variants of Adrenocortical Carcinoma: Analysis of Rare Variants in Single Tertiary Care Center.
Sung TY; Choi YM; Kim WG; Lee YM; Kim TY; Shong YK; Kim WB; Song DE
J Korean Med Sci; 2017 May; 32(5):764-771. PubMed ID: 28378549
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological and Prognostic Characteristics of CD276 (B7-H3) Expression in Adrenocortical Carcinoma.
Liang J; Liu Z; Pei T; Xiao Y; Zhou L; Tang Y; Zhou C; Wu K; Zhang F; Zhang F; Yin X; Chen N; Wei X; Lu Y; Zhu Y
Dis Markers; 2020; 2020():5354825. PubMed ID: 31998416
[TBL] [Abstract][Full Text] [Related]
9. [Adrenocortical cancer: morphological variants, immunohistochemical characteristics].
Tkachuk AV; Tertychnyi AS; Beltsevich DG; Roslyakova AA; Belousov PV; Selivanova LS
Arkh Patol; 2021; 83(3):10-18. PubMed ID: 33822549
[TBL] [Abstract][Full Text] [Related]
10. Fascin-1 Is a Novel Prognostic Biomarker Associated With Tumor Invasiveness in Adrenocortical Carcinoma.
Poli G; Ruggiero C; Cantini G; Canu L; Baroni G; Armignacco R; Jouinot A; Santi R; Ercolino T; Ragazzon B; Assie G; Mannelli M; Nesi G; Lalli E; Luconi M
J Clin Endocrinol Metab; 2019 May; 104(5):1712-1724. PubMed ID: 30476173
[TBL] [Abstract][Full Text] [Related]
11. High diagnostic and prognostic value of steroidogenic factor-1 expression in adrenal tumors.
Sbiera S; Schmull S; Assie G; Voelker HU; Kraus L; Beyer M; Ragazzon B; Beuschlein F; Willenberg HS; Hahner S; Saeger W; Bertherat J; Allolio B; Fassnacht M
J Clin Endocrinol Metab; 2010 Oct; 95(10):E161-71. PubMed ID: 20660055
[TBL] [Abstract][Full Text] [Related]
12. New Findings on Presentation and Outcome of Patients With Adrenocortical Cancer: Results From a National Cohort Study.
Puglisi S; Calabrese A; Ferraù F; Violi MA; Laganà M; Grisanti S; Ceccato F; Scaroni C; Di Dalmazi G; Stigliano A; Altieri B; Canu L; Loli P; Pivonello R; Arvat E; Morelli V; Perotti P; Basile V; Berchialla P; Urru S; Fiori C; Porpiglia F; Berruti A; Pia A; Reimondo G; Cannavò S; Terzolo M
J Clin Endocrinol Metab; 2023 Sep; 108(10):2517-2525. PubMed ID: 37022947
[TBL] [Abstract][Full Text] [Related]
13. A Clinicopathological Analysis of Asian Patients with Adrenocortical Carcinoma: A Single-Center Experience.
Tsai WH; Dai SH; Lee CC; Chien MN; Zeng YH
Curr Oncol; 2023 Apr; 30(4):4117-4125. PubMed ID: 37185426
[TBL] [Abstract][Full Text] [Related]
14. Development and Validation of an m6A RNA Methylation Regulators-Based Signature for Predicting the Prognosis of Adrenocortical Carcinoma.
Shen C; Liu J; Yang X; Jiao W; Wang Y
Front Endocrinol (Lausanne); 2021; 12():568397. PubMed ID: 33692753
[TBL] [Abstract][Full Text] [Related]
15. Prognostic predictors of adrenocortical carcinoma: A single-center thirty-year experience.
Pan LH; Yen CC; Huang CJ; Ng XN; Lin LY
Front Endocrinol (Lausanne); 2023; 14():1134643. PubMed ID: 36967802
[TBL] [Abstract][Full Text] [Related]
16. Survival and prognostic factors for adrenocortical carcinoma: a single institution experience.
Loncar Z; Djukic V; Zivaljevic V; Pekmezovic T; Diklic A; Tatic S; Dundjerovic D; Olujic B; Slijepcevic N; Paunovic I
BMC Urol; 2015 May; 15():43. PubMed ID: 26013141
[TBL] [Abstract][Full Text] [Related]
17. Proposal for modification of the ENSAT staging system for adrenocortical carcinoma using tumor grade.
Miller BS; Gauger PG; Hammer GD; Giordano TJ; Doherty GM
Langenbecks Arch Surg; 2010 Sep; 395(7):955-61. PubMed ID: 20694732
[TBL] [Abstract][Full Text] [Related]
18. European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors.
Fassnacht M; Dekkers OM; Else T; Baudin E; Berruti A; de Krijger R; Haak HR; Mihai R; Assie G; Terzolo M
Eur J Endocrinol; 2018 Oct; 179(4):G1-G46. PubMed ID: 30299884
[TBL] [Abstract][Full Text] [Related]
19. Circulating Fascin 1 as a Promising Prognostic Marker in Adrenocortical Cancer.
Cantini G; Fei L; Canu L; De Filpo G; Ercolino T; Nesi G; Mannelli M; Luconi M
Front Endocrinol (Lausanne); 2021; 12():698862. PubMed ID: 34248854
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and prognostic role of steroidogenic factor 1 in adrenocortical carcinoma: a validation study focusing on clinical and pathologic correlates.
Duregon E; Volante M; Giorcelli J; Terzolo M; Lalli E; Papotti M
Hum Pathol; 2013 May; 44(5):822-8. PubMed ID: 23158211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]